Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates

被引：0
|
作者：
Shwu-Maan Lee
Chia-Kuei Wu
Jordan Plieskatt
David H. McAdams
Kazutoyo Miura
Chris Ockenhouse
C. Richter King
机构：
[1] PATH Malaria Vaccine Initiative (MVI),Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases
[2] PATH,undefined
[3] National Institutes of Health,undefined
来源：
Malaria Journal | / 15卷
关键词：
Malaria; Pfs25; Transmission blocking vaccine; Baculovirus; Glycosylation; Recombinant protein;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates
    Lee, Shwu-Maan
    Wu, Chia-Kuei
    Plieskatt, Jordan
    McAdams, David H.
    Miura, Kazutoyo
    Ockenhouse, Chris
    King, C. Richter
    MALARIA JOURNAL, 2016, 15 : 1 - 12
  • [2] Expression of malaria transmission-blocking vaccine antigen Pfs25 in Pichia pastoris for use in human clinical trials
    Zou, LL
    Miles, AP
    Wang, J
    Stowers, AW
    VACCINE, 2003, 21 (15) : 1650 - 1657
  • [3] Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25
    Stephen W. Scally
    Brandon McLeod
    Alexandre Bosch
    Kazutoyo Miura
    Qi Liang
    Sean Carroll
    Sini Reponen
    Ngan Nguyen
    Eldar Giladi
    Sebastian Rämisch
    Vidadi Yusibov
    Allan Bradley
    Franck Lemiale
    William R. Schief
    Daniel Emerling
    Paul Kellam
    C. Richter King
    Jean-Philippe Julien
    Nature Communications, 8
  • [4] Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25
    Scally, Stephen W.
    McLeod, Brandon
    Bosch, Alexandre
    Miura, Kazutoyo
    Liang, Qi
    Carroll, Sean
    Reponen, Sini
    Nguyen, Ngan
    Giladi, Eldar
    Ramisch, Sebastian
    Yusibov, Vidadi
    Bradley, Allan
    Lemiale, Franck
    Schief, William R.
    Emerling, Daniel
    Kellam, Paul
    King, C. Richter
    Julien, Jean-Philippe
    NATURE COMMUNICATIONS, 2017, 8
  • [5] Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer
    Kazutoyo Miura
    David B Keister
    Olga V Muratova
    Jetsumon Sattabongkot
    Carole A Long
    Allan Saul
    Malaria Journal, 6
  • [6] Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer
    Miura, Kazutoyo
    Keister, David B.
    Muratova, Olga V.
    Sattabongkot, Jetsumon
    Long, Carole A.
    Saul, Allan
    MALARIA JOURNAL, 2007, 6 (1)
  • [7] Effect of CpG oligodeoxynucleotides on the immunogenicity of Pfs25, a Plasmodium falciparum transmission-blocking vaccine antigen
    Coban, C
    Ishii, KJ
    Stowers, AW
    Keister, DB
    Klinman, DM
    Kumar, N
    INFECTION AND IMMUNITY, 2004, 72 (01) : 584 - 588
  • [8] Pfs230 yields higher malaria transmission-blocking vaccine activity than Pfs25 in humans but not mice
    Healy, Sara A.
    Anderson, Charles
    Swihart, Bruce J.
    Mwakingwe, Agnes
    Gabriel, Erin E.
    Decederfelt, Hope
    Hobbs, Charlotte, V
    Rausch, Kelly M.
    Zhu, Daming
    Muratova, Olga
    Herrera, Raul
    Scaria, Puthupparampil, V
    MacDonald, Nicholas J.
    Lambert, Lynn E.
    Zaidi, Irfan
    Coelho, Camila H.
    Renn, Jonathan P.
    Wu, Yimin
    Narum, David L.
    Duffy, Patrick E.
    JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (07):
  • [9] Functional immunogenicity of baculovirus expressing Pfs25, a human malaria transmission-blocking vaccine candidate antigen
    Mlambo, Godfree
    Kumar, Nirbhay
    Yoshida, Shigeto
    VACCINE, 2010, 28 (43) : 7025 - 7029
  • [10] Structural delineation of human antibody responses against malaria transmission-blocking vaccine antigen Pfs25
    McLeod, Brandon
    Miura, Kazutoyo
    Scally, Stephen W.
    Bosch, Alexandre
    Ramisch, Sebastian
    Yusibov, Vidadi
    Schief, William R.
    Emerling, Daniel
    King, C. Richter
    Julien, Jean-Philippe
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2018, 74 : A255 - A255
12345